Segment Information (Tables)

6 Months Ended

Mar. 31, 2012

Financial Information for Business Segments

Financial information for the Company’s business segments is as follows (in thousands):

	Brooks Product Solutions		Brooks Global Services		Brooks Life Science Systems			Contract Manufacturing		Total
Three months ended March 31, 2012
Revenues
Product	$	103,456	$	3,015	$	11,150		$	—	$	117,621
Services		—		18,220		3,496			—		21,716
	$	103,456	$	21,235	$	14,646		$	—	$	139,337
Gross profit	$	35,885	$	6,591	$	5,806		$	—	$	48,282
Segment operating income	$	7,597	$	2,195	$	(105	)	$	—	$	9,687
Three months ended March 31, 2011
Revenues
Product	$	121,664	$	4,149	$	—		$	49,123	$	174,936
Services		—		17,715		—			—		17,715
	$	121,664	$	21,864	$	—		$	49,123	$	192,651
Gross profit	$	47,490	$	7,920	$	—		$	6,264	$	61,674
Segment operating income	$	20,677	$	3,062	$	—		$	4,000	$	27,739
Six months ended March 31, 2012
Revenues
Product	$	188,750	$	5,392	$	20,577		$	—	$	214,719
Services		—		37,937		6,909			—		44,846
	$	188,750	$	43,329	$	27,486		$	—	$	259,565
Gross profit	$	64,286	$	13,727	$	10,626		$	—	$	88,639
Segment operating income	$	8,682	$	5,144	$	(738	)	$	—	$	13,088
Six months ended March 31, 2011
Revenues
Product	$	233,665	$	7,447	$	—		$	95,013	$	336,125
Services		—		34,893		—			—		34,893
	$	233,665	$	42,340	$	—		$	95,013	$	371,018
Gross profit	$	90,580	$	15,187	$	—		$	13,226	$	118,993
Segment operating income	$	38,148	$	5,572	$	—		$	8,643	$	52,363
Assets
March 31, 2012	$	225,588	$	57,192	$	109,314		$	—	$	392,094
September 30, 2011	$	235,322	$	52,354	$	101,331		$	—	$	389,007

Reconciliation of Reportable Segment Operating Income to Corresponding Consolidated Amounts

A reconciliation of the Company’s reportable segment operating income to the corresponding consolidated amounts for the three and six month periods ended March 31, 2012 and 2011 is as follows (in thousands):

	Three months ended March 31,					Six months ended March 31,
	2012			2011		2012			2011
Segment operating income	$	9,687		$	27,739	$	13,088		$	52,363
Other unallocated corporate expenses		(2,934	)		303		(2,416	)		534
Amortization of acquired intangible assets		1,138			449		2,355			899
Restructuring charges		42			246		245			460
In-process research and development		3,026			—		3,026			—
Total operating income	$	8,415		$	26,741	$	9,878		$	50,470

Reconciliation of Reportable Segment Assets to Corresponding Consolidated Amounts

A reconciliation of the Company’s reportable segment assets to the corresponding consolidated amounts as of March 31, 2012 and September 30, 2011 is as follows (in thousands):

	March 31, 2012		September 30, 2011
Segment assets	$	392,094	$	389,007
Investments in cash equivalents, marketable securities, joint ventures, and other unallocated corporate net assets		244,582		247,613
Total assets	$	636,676	$	636,620